86exporter.com Home       Products Catalog      Suppliers Catalog      Log In        Sign up
      About Us
      Profile
      Products
      Contact Us


BGI Genomics

Showing 41 - 50 of 75, total 8 pages        [First] [Previous] [Next] [Last]

41
exactly how blood groups are acquired and also why it ¡ä s crucia
exactly how blood groups are acquired and also why it ¡ä s crucia
Specification: Exactly how blood groups are acquired and also why it ¡ä s crucia
Detail: Do you understand your blood group? This is a question we ought to all be able to answer. It includes vital information for scenarios such as blood contributions, transfusions or maternities. It is likewise very intriguing to ...

42
hereditary alterations: the different causes as well as kinds
hereditary alterations: the different causes as well as kinds
Specification: Hereditary alterations: the different causes as well as kinds
Detail: Did you recognize that all people share 99.9% of their hereditary info? This implies our uniqueness depends on the remaining 0.1%, which varies between people and also ***ermines our physical characteristics (phenotype), along...

43
dna drawn out from blood and various other resources exactly how
dna drawn out from blood and various other resources exactly how
Specification: DNA drawn out from blood and various other resources exactly how
Detail: Drawing out DNA from blood sounds like a forensic practice we would certainly see on television shows, however what is its energy? While blood is among the most generally used examples to extract DNA, there are other resources...

44
beijing genomics institute (bgi)¡¯s first bgiseq-500 in asia paci
beijing genomics institute (bgi)¡¯s first bgiseq-500 in asia paci
Specification: Beijing Genomics Institute (BGI)¡¯s First BGISEQ-500 in Asia Paci
Detail: NIFTY/NIPT is currently the most extensive and successful clinical application of NGS, with the global rising trend of precision medicine, the future demand of NGS applications in other field will for sure be vigorous. The pro...

45
bgi statement in response to reuters report
bgi statement in response to reuters report
Specification: BGI Statement in Response to Reuters Report
Detail: SHENZHEN, China, July 9, 2021 /PRNewswire/ -- BGI is aware of reports in Reuters regarding the co***ny¡¯s non-invasive prenatal test (NIPT test) - NIFTY (Non-Invasive Fetal TrisomY). BGI¡¯s NIPT tests (one kind of BGI gene te...

46
china genomics giant drops plans for gene-edited pets
china genomics giant drops plans for gene-edited pets
Specification: China Genomics Giant Drops Plans for Gene-Edited Pets
Detail: China¡¯s largest BGI gene test co***ny is going public. But hold the bacon. Starting this week, investors should be able to buy shares in BGI, China¡¯s largest genomics co***ny, as it completes a $251 million initial public o...

47
bgi is granted patent in 16 countries for non-invasive prenatal
bgi is granted patent in 16 countries for non-invasive prenatal
Specification: BGI is granted patent in 16 countries for non-invasive prenatal
Detail: BGI Dx has developed a series of BGI gene test services based on multidisciplinary technologies and approaches, including independent core technologies such as high throughput sequencing, high sensitivity mass spectrum and big...

48
natera and bgi genomics announce $50m partnership to commerciali
natera and bgi genomics announce $50m partnership to commerciali
Specification: Natera and BGI Genomics Announce $50M Partnership to Commerciali
Detail: SAN CARLOS, Calif. and SHENZHEN, China, March 11, 2019 /PRNewswire/ ¡ª Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA genetic testing, and BGI Genomics Co., Ltd., (300676.SZ), the largest cell-free DNA clinica...

49
bgi genomics
bgi genomics
Specification: BGI Genomics
Detail: BGI was founded in 1999 as a research organization to support the Human Genome Project. Over the years, BGI¡¯s in-house research has contributed to the development of the field of Genomics in significant ways, as evidenced by ...

50
bgi genomics h1 revenues fall 11 percent on covid-19 testing dec
bgi genomics h1 revenues fall 11 percent on covid-19 testing dec
Specification: BGI Genomics H1 Revenues Fall 11 Percent on COVID-19 Testing Dec
Detail: NEW YORK ¨C Chinese diagnostics firm BGI Genomics reported last week that its H1 2021 revenues declined 11 percent due to decreasing demand for COVID-19 testing. Total revenues were RMB 3.6 billion ($560 million), down from R...
Showing 41 - 50 of 75, total 8 pages        [First] [Previous] [Next] [Last]
1 2 3 4 5 6 7 8


Copyright© BGI Genomics All Rights Reserved.
Tel : 17722567742 Fax :
Powered by 86exporter.com